|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-3-14
|
|
pubmed:abstractText |
To assess the value of changes in the expression of topoisomerase IIalpha (TopoII) and the proto-oncogene erbB-2 (HER-2) as predictors of relapse-free survival in women with operable breast cancer treated with anthracycline-based neoadjuvant chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type II,
http://linkedlifedata.com/resource/pubmed/chemical/DNA topoisomerase II alpha,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:AlbertiSaverioS,
pubmed-author:AngelucciDomenicoD,
pubmed-author:CianchettiEttoreE,
pubmed-author:FicorellaCorradoC,
pubmed-author:IacobelliStefanoS,
pubmed-author:LattanzioRossanoR,
pubmed-author:MarchettiPaoloP,
pubmed-author:NatoliClaraC,
pubmed-author:PiantelliMauroM,
pubmed-author:RicevutoEnricoE,
pubmed-author:TinariNicolaN
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1501-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16533774-Adult,
pubmed-meshheading:16533774-Aged,
pubmed-meshheading:16533774-Antigens, Neoplasm,
pubmed-meshheading:16533774-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16533774-Breast Neoplasms,
pubmed-meshheading:16533774-Cyclophosphamide,
pubmed-meshheading:16533774-DNA Topoisomerases, Type II,
pubmed-meshheading:16533774-DNA-Binding Proteins,
pubmed-meshheading:16533774-Disease-Free Survival,
pubmed-meshheading:16533774-Drug Resistance, Neoplasm,
pubmed-meshheading:16533774-Epirubicin,
pubmed-meshheading:16533774-Female,
pubmed-meshheading:16533774-Fluorouracil,
pubmed-meshheading:16533774-Humans,
pubmed-meshheading:16533774-Mastectomy,
pubmed-meshheading:16533774-Middle Aged,
pubmed-meshheading:16533774-Neoadjuvant Therapy,
pubmed-meshheading:16533774-Neoplasm, Residual,
pubmed-meshheading:16533774-Neoplasm Invasiveness,
pubmed-meshheading:16533774-Neoplasm Recurrence, Local,
pubmed-meshheading:16533774-Prognosis,
pubmed-meshheading:16533774-Receptor, erbB-2,
pubmed-meshheading:16533774-Stereoisomerism
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.
|
|
pubmed:affiliation |
G. D'Annunzio University Foundation and Department of Oncology and Neurosciences, University G. D'Annunzio Medical School, Chieti, Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
